...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM webcast 9/12/2018

Listen for the word "deal" a couple of minutes one side or the other of "things are going to get interesting soon"

Q&A will be included with the Zenith narrative.

tada

Share
New Message
Please login to post a reply